Literature DB >> 12622460

C-Med 100, a hot water extract of Uncaria tomentosa, prolongs lymphocyte survival in vivo.

Ch Akesson1, R W Pero, F Ivars.   

Abstract

Water extracts of the bark of Uncaria tomentosa, a vine indigenous to South America, has been used for generations as an "immuno modulator". To understand the basis of this immuno modulatory effect we fed mice in their drinking water with C-Med 100, which is a commercially available water extract from Uncaria tomentosa. We found a dose-dependent increase in spleen cell numbers in the supplemented mice, but the proportions of B cells, T cells, NK cells, granulocytes, and memory lymphocytes were normal. However, there were no detectable changes of the lymphoid architecture of the spleen even after long-term treatment. Further, when C-Med 100 treatment was interrupted the cellularity returned to normal level within four weeks. The increased number of lymphocytes was most likely not due to increased production because C-Med 100 did not have any significant effect on precursor cells nor on the accumulation of recent thymic emigrants in the spleen. We conclude that accumulation is most likely due to prolonged cell survival, because adoptive transfer experiments demonstrated that C-Med 100 treatment significantly prolonged lymphocyte survival in peripheral lymphoid organs, without increasing their proliferation rate. Since the accumulation was reversible and without detectable pathological effects, these results suggest the use of C-Med 100 as a potential agent for clinically accelerating the recovery of patients from leukopenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622460     DOI: 10.1078/094471103321648629

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  4 in total

1.  Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial.

Authors:  I L G Farias; M C S Araújo; J G Farias; L V Rossato; L I Elsenbach; S L Dalmora; N M P Flores; M Durigon; I B M Cruz; V M Morsch; M R C Schetinger
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-21       Impact factor: 2.629

2.  Uncaria tomentosa-Adjuvant Treatment for Breast Cancer: Clinical Trial.

Authors:  Maria do Carmo Santos Araújo; Iria Luiza Farias; Jessie Gutierres; Sergio L Dalmora; Nélia Flores; Julia Farias; Ivana de Cruz; Juarez Chiesa; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-28       Impact factor: 2.629

3.  Uncaria tomentosa (Willd. ex Schult.) DC (Rubiaceae) Sensitizes THP-1 Cells to Radiation-induced Cell Death.

Authors:  Lisa Allen; Alison Buckner; Carly A Buckner; Pablo Cano; Robert M Lafrenie
Journal:  Pharmacognosy Res       Date:  2017 Jul-Sep

4.  Treatment with Uncaria tomentosa Promotes Apoptosis in B16-BL6 Mouse Melanoma Cells and Inhibits the Growth of B16-BL6 Tumours.

Authors:  Ali Zari; Hajer Alfarteesh; Carly Buckner; Robert Lafrenie
Journal:  Molecules       Date:  2021-02-18       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.